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One of the major challenges in producing large scale engineered tissue is the lack of ability to create large highly
perfused scaffolds in which cells can grow at a high cell density and viability. Here, we explore 3D printed poly-
vinyl alcohol (PVA) as a sacriﬁcialmould in a polymer casting process. The PVAmould network deﬁnes the chan-
nels and is dissolved after curing the polymer casted around it. The printing parameters determined the PVA
ﬁlament density in the sacriﬁcial structure and this density resulted in different stiffness of the corresponding
elastomer replica. It was possible to achieve 80% porosity corresponding to about 150 cm2/cm3 surface to volume
ratio. The process is easily scalable as demonstrated by fabricating a 75 cm3 scaffold with about 16,000 intercon-
nected channels (about 1 m2 surface area) and with a channel to channel distance of only 78 μm. To our knowl-
edge this is the largest scaffold ever to be produced with such small feature sizes and with so many structured
channels. The fabricated scaffolds were applied for in-vitro culturing of hepatocytes over a 12-day culture period.
Smaller scaffolds (6× 4mm)were tested for cell culturing and could support homogeneous cell growth through-
out the scaffold. Presumably, the diffusion of oxygen and nutrient throughout the channel network is rapid
enough to support cell growth. In conclusion, the described process is scalable, compatible with cell culture,
rapid, and inexpensive.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
In recent years, there has been a great demand for the development
of bioartiﬁcial organs/tissues in the ﬁeld of organ transplantation and
in vitro toxicological drug screening [1]. One of the primary challenges
in translation of tissue engineering to clinical application is the difﬁculty
in scaling up complex, biological effective tissues and organs to the size
relevant for human [2]. Although small scale three-dimensional (3D)
scaffold constructs have been achieved to mimic organs for e.g.,
in vitro drug testing [3], the applied fabrication approaches are not eas-
ily translated to constructs of human organ size. When engineering tis-
sues in vitro, there is a requirement for structures or scaffolds that are
able to support cell growth and at the same time mimicking the physi-
ological environment including the geometrical, topographical and
physical features of the targeted tissue. Speciﬁcally for the generation
of thick 3D tissues, the development of highly dense vascular networks
that can meet the nutrient and oxygen requirements of large masses of
living cells remains a tissue engineering challenge. This often limits the
size of engineered tissues to a few hundred micrometres [4]. The ideal
tissue engineering scaffold supports the spatial distribution of cells in
a three dimensional structure, provides mechanical stability to the
cells and enables optimum nutrient transport and metabolic waste
removal [5,6]. Numerous approaches exist to create 3D highly
vascularized engineered tissue scaffolds to accommodate a high density
of cells in high surface to volume ratio structures [6,7]. One strategy has
been to use highly porous structures with interconnected pores/
microchannels that provide space for penetration and growth of cells
and enable favourable mass transport characteristics [8,9]. The struc-
tural, mechanical and mass transport properties of such scaffolds are
determined by parameters such as pore size, pore shape, porosity,
pore interconnectivity, permeability, scaffold surface area, scaffold ef-
fective stiffness and scaffold material [10].
Scaffolds consisting of stochastic, disordered or random micropores
are one of the oldest and most widely used templates for tissue engi-
neering [11,12]. Manufacturing techniques such as solvent casting-
particulate leaching [13], phase separation [14], gas foaming [15],
emulsion freeze drying [16] and ﬁbre meshes [17] have been used to
generate engineered scaffolds of foam-like internal structure with a
random architecture and a limited control of scale [18]. Although such
processing techniques are quick, scalable and economical, they do not
enable accurate control of the microarchitectural details such as the
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pore size, geometry, their interconnections and distribution within the
scaffold [19]. The possibility to control the inner architecture of scaffolds
is desirable as it enables the control over itsmechanical strength, the ef-
fective surface area for cell growth, and nutrientﬂowproﬁleswithin the
scaffold [18]. To produce scaffolds with ﬁne control over scaffold archi-
tecture in three dimensions, layer-by layer assembly techniques, where
layers of polymers, patterned by moulding or embossing processes, are
stacked, have been investigated by many researchers [20,21]. These
techniques enable the formation of channels with precisely deﬁned di-
mensions. However, the requirement for microfabricated master
moulds andmanual alignment of layers implies a slow and tedious pro-
cess for achieving a multi-layered 3D construct [22].
Recently there has been amove towards employing 3D printing [10,
23,24] as a rapid prototyping technique to fabricate micro-scale porous
structures of desired complexities, allowing a true engineering of the
scaffold [18]. These methods involve the creation of 3D objects using
layer by layer deposition approach. Such techniques have successfully
been employed in tissue engineering to develop scaffolds based on
hard polymeric materials [25,26] and hydrogels [27,28]. The application
of scaffolds made from soft polymers or elastomeric materials is desir-
ablewhen engineering soft tissues [12,29,30]. For the fabrication of elas-
tomeric scaffolds with microﬂuidic networks, micromoulding and
individual layer-by layer assembly techniques have commonly been
used [20,31]. However such techniques require the use of complex fab-
rication technologies and manual assembly for producing large scale
structures. Thus the fabrication of 3D elastomeric scaffoldswith deﬁned
microarchitectural details in cost-effective, scalable manner remains a
challenge.
Recently, processes combining 3D printing and moulding have been
used for making structured 3D scaffolds. For example, 3Dmicrovascular
networks within polymer matrices have been fabricated by 3D printing
of sacriﬁcial wax moulds, casting of low viscosity epoxy around the
moulds and subsequent removal of the moulds [23,32]. However the
use of wax (which has a melting temperature of about 60 °C) limits
the materials that can be cast around the mould to form the scaffold
since polymers requiring higher temperatures for cross-linking cannot
be employed. Furthermore, the complete removal of the sacriﬁcial
wax components (whichmaynot be biocompatible) can be challenging,
in particular if you have a large 3D structure with complex geometry.
Perfusable 3D scaffolds have also been demonstrated in a similar man-
ner by casting extracellular matrix (ECM) containing cells around a 3D
printed sacriﬁcial sugar glass lattice and subsequently dissolving the lat-
tice to form vascular networks [24]. However, it is probably difﬁcult to
print large 3D structures in the very brittle sugar glass, and the
interﬁlament distance (deﬁned by the printing process) is limited to a
minimumof 1mm. Itmay therefore not be feasible to use this technique
for creating dense vascular channels in large scale structures.
This paper presents a new scalable and general approach for
manufacturing structured pores/channels in 3D polymer based scaf-
folds. The method involves 3D printing (using a commercially available
ﬁlament based 3D printer) of a sacriﬁcial polyvinyl alcohol (PVA)mould
whose geometrical features are designed according to the required vas-
cular channel network. In addition to its biocompatibility, PVA is an
ideal material because its water solubility in combination with its high
melting temperature (190 °C) makes it robust for subsequent polymer
casting and curing steps. A desired polymer is cast around the PVA
mould, cross-linked and then the mould is dissolved, leaving behind a
structured porous scaffold in the desired polymermaterial. The fabrica-
tion method was here demonstrated for two different polymers, the
silicone elastomer polydimethylsiloxane (PDMS), and the synthetic hy-
drogel poly(2-hydroxyethyl methacrylate) (pHEMA). The scalability of
themethodwas demonstrated by fabricating a 75 cm3 large PDMS scaf-
fold structure with 16,000 channels. Moreover, it was also shown that
the PDMS scaffolds when properly pre-treated could support hepato-
cyte growth and proliferation for up to 12 days with high viability and
proper function.
2. Materials and methods
2.1. Fabrication of structured porous elastomeric scaffolds
The method used to fabricate elastomeric polymer scaffolds with
structured channels is schematically presented in Fig. 1. First, a com-
mercial, low-cost 3D ﬁlament printer (MakerBot 2X) was used to print
Fig. 1. Schematic illustration of the steps involved in the fabrication of structured porous elastomeric scaffolds. A sacriﬁcial 3Dmouldwas printed in PVA (a, b). The printed PVAmouldwas
transferred into a container containing pre-cured PDMS (c). Vacuumwas applied to ensure complete ﬁlling of pre-cured PDMS into the pores of the mould (d). Following crosslinking of
the PDMS, the sacriﬁcial PVA mould was dissolved in water (e) leaving behind the structured PDMS scaffold (f).
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a sacriﬁcial mould. A solid 3D cube of the speciﬁed length, width and
height was designed using a computer aided design (CAD) software
package (SolidWorks 2013). The 3D CAD design was exported as
.STL mesh ﬁle format for processing using the 3D printer software
(Makerware 2.4.1,MakerBot). Commercially availablewater dissolvable
polymer, polyvinyl alcohol (PVA) (MakerBot, USA) ﬁlaments were
used to print the sacriﬁcialmould. In the printing process amoving noz-
zle (x- and y-axis control) extrudes a heated polymer ﬁlament which
then solidiﬁes as it is deposited (Fig. 1(a)). Following deposition of
each layer, themould is lowered (z-axis control) and the extrusion pro-
cedure is repeated such that successive layers are built on top of each
other to form a 3D object (Fig. 1(b)). The printer settings used for print-
ing PVA moulds are given in Table 1. The extrusion temperature and
feed-rates were optimised for printing PVA.
The printing inﬁll density was varied to generate structures with
varying porosity. The inﬁll density is the parameter that deﬁnes the
amount of material ﬁlled into the object and subsequently relates to
the porosity of the 3D printed structure. The inﬁll density can range
from 0% to 100%, where 0% results in a completely hollow object and
100% inﬁll results in a completely solid object. In order to generate
structures with different porosities, moulds were printed with inﬁll
densities ranging from 20% to 80%. An illustration of the inﬁll patterns
and densities that were employed is shown in Supplementary Fig. 1.
The 3D printed microvascular network of the PVA mould was repli-
cated into elastomeric structures of polydimethylsiloxane (PDMS):
PDMS pre-polymer solution (Sylgard 184, Dow Corning) was mixed
with the curing agent in a 10:1 ratio (as per the manufacturer's guide-
lines). The mixture was degassed in vacuum and poured into a petri
dish containing the printed mould (Fig. 1(c)). PDMS ﬁlls the pores of
the mould through capillary action and, in addition, vacuum was ap-
plied for 2–3 h to ensure complete ﬁlling of the micro-channels of the
mould with PDMS (Fig. 1(d)). PDMS was cured at a temperature of
60 °C in an oven for 4 h. Once cured, excess PDMS around the mould
was removed to expose the PVA layer. This was done to assist the sub-
sequent dissolution of PVA inwater: Thewhole structurewas immersed
into a water bath (Fig. 1(e)) until the PVA mould was completely dis-
solved (6 h), and the elastomeric PDMSwithmicrovascular network ar-
chitecture was obtained (Fig. 1(f)).
Cuboidal PVA moulds of 25 × 25 × 10 mm3 and 25 × 25 × 4 mm3
(length ×width × height) were printed and used for casting PDMS scaf-
folds and these scaffolds were used for mechanical testing and cell cul-
turing studies respectively.
2.2. Characterizations of scaffolds
2.2.1. Scanning electron microscopy (SEM) imaging
The structural morphology and microstructure of the printed PVA
mould as well as the resulting PDMS porous scaffolds were analysed
using scanning electron microscopy (JEOL, Tokyo, Japan). Prior to SEM
analysis, moulds and scaffolds were dried in an oven at 50 °C overnight
and sputter coated with gold. Samples were then analysed using 12 kV
of accelerating voltage. Pore sizes of themoulds and scaffoldsweremea-
sured from SEM micrographs using ImageJ software. For each sample,
ten measurements of pore dimensions were acquired.
For cell-seeded scaffolds, samples were washed with PBS and ﬁxed
with 2.5% glutaraldehyde in PBS overnight. Next the samples were
dehydrated in a series of ethanol solutions (50%, 70%, 90% and 100%),
the samples were further air-dried and then the samples were ready
for SEM observation.
2.2.2. Porosity measurement
The porosity of the PDMS scaffold wasmeasured using Eq. (1) as de-
scribed in the literature [33].
Porosity %ð Þ ¼
V−
M
ρ
 
V
 100% ð1Þ
where V is the volume of the scaffold, which is calculated using its outer
dimension, M is themass of the porous PDMS scaffold, and ρ is the den-
sity of PDMS (0.965 g/cm3).
Four scaffolds from each type of scaffold (with dimensions
23 × 23 × 6mm3) were dried overnight at 80 °C, andweighed to obtain
the mass of the samples. The porosity was then calculated from the
weight and the dimensions using Eq. (1).
2.2.3. Mechanical testing
The mechanical properties of dry PDMS scaffolds (with dimensions
of 25 × 25 × 10 mm3) of varying porosity (20–80%) were tested by
conducting uniaxial compression tests. A constant compression speed
of 0.5 mm/min was applied to each sample using a tensile test machine
with a 5 kN load cell (INSTRONModel 4301, Instron Engineering Corpo-
ration, Canton, MA, USA). The compressive modulus was estimated
from the slope of the stress–strain curve in the elastic region, which
was in the range of 12%–20% strain. The stress at 20% strain was obtain-
ed. The values reported were an average from four tested samples.
2.2.4. Surface roughness
The surface topography of the PVA mould and PDMS scaffold was
visualised using SEM. PDMS scaffold surface roughness was measured
using an optical measuring device (Alicona inﬁnite focus). The parame-
ters Ra and Rz were obtained from a standard spectrum of roughness.
2.2.5. Wettability
To assess wettability of the scaffolds, contact angle measurements
were carried out on scaffolds before and after treatment with oxygen
plasma. The contact angle wasmeasured using the sessile drop method
by depositing 3 μl of an ultrapure water drop on the scaffold. Three indi-
vidual measurements were carried out on three independent scaffolds.
2.2.6. Surface area calculation
To estimate the surface area of the scaffolds, the dimensions of the
ﬁlaments constituting the mould were acquired from SEM images of
the mould. As previously described, the scaffold is formed by printing
layers of ﬁlaments (with a height of 0.2 mm) organised in the x–y
axis. The surface area was calculated from the SEM images of a single
layer and then multiplied by the number of layers.
2.3. Culturing cells in scaffolds
2.3.1. Cells
Human hepatoblastoma (HepG2) cells were obtained from the
German Collection of Microorganisms and Cell Cultures (DSMZ,
Braunschweig, Germany). The cells were maintained in Roswell Park
Memorial Institute (RPMI) 1640 growth medium supplemented
with 10% foetal bovine serum (FBS, Sigma-Aldrich Chemie GmbH,
Switzerland) and 100 μg/ml penicillin and 10 μg/ml streptomycin in a
humidiﬁed incubator at 37 °C and 5% CO2. Cells were cultured to conﬂu-
ence in standard polystyrene cell culture ﬂasks, and then released using
0.025% trypsin/EDTA solution. The cell suspension was centrifuged and
the cell pellet was washed twice with phosphate buffered saline (PBS)
and then re-suspended in fresh growth medium. The cell density was
Table 1
3D printing parameters used for fabricating sacriﬁcial PVA mould.
3D printing parameters Settings
Layer height 0.2 mm
Inﬁll pattern Woodpile or hexagonal
Nozzle temperature 200 °C
Build platform temperature 40 °C
Feed-rate 20 mm/s
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measured using a haemocytometer and adjusted as required for the
seeding on the 3D scaffolds.
2.3.2. Scaffold preparation for cell culture
PDMS scaffolds (fabricated with 80% inﬁll moulds) were frozen in
liquid nitrogen and punched into cylindrical scaffolds (having a diame-
ter of 6 mm and height 4 mm) using a tissue puncher (Harris Uni-Core,
USA). To render them hydrophilic, the scaffolds weremodiﬁedwith ox-
ygen plasma using a 13.56MHz RF generator equipped Atto Plasma Sys-
tem (Diener Electronic GmbH, Ebhausen, Germany). Initially the plasma
chamber was evacuated to a pressure below 15 Pa, after which oxygen
was introduced (pressure stabilization at 30 Pa) and the plasma was
ignited (power 50 W) for a duration of 2 min for each side of the scaf-
fold. The treated scaffolds were transferred into an autoclavable glass
vial containing sterile water and autoclaved at 120 °C for 20 min for
sterilisation. To promote cell attachment to the scaffolds, the scaffolds
were coated with 40 μg/ml of Collagen I (Collagen I rat protein, Life
Technologies, A1048301) at 4 °C overnight. The scaffolds were washed
twice with phosphate buffered saline (PBS) and excess collagen was
removed by centrifugation of the samples at 1000 rpm. Finally, the scaf-
folds were placed in a petri dish containing RPMI medium and incubat-
ed inside a humidiﬁed incubator at 37 °C and 5% CO2 for 2 h prior to cell
seeding.
2.3.3. Cultivation of HepG2 cells inside the scaffolds
HepG2 cells were cultured in the fabricated scaffolds to evaluate the
ability of PDMS 3D constructs to support cell adhesion, proliferation and
spreading. For cell seeding a customised cell loading platform was de-
veloped as shown schematically in Supplementary Fig. 2. A cell seeding
plate with 16 cylindrical holes (having a diameter of 6 mm) and a rect-
angular support framewas fabricated in 6mm thick Poly(methyl meth-
acrylate) (PMMA) using a CO2 laser cutter machine (Epilog Mini 18
Laser, CO 80403, USA). The seeding plate and frame were sterilised by
immersion in 0.5M sodium hydroxide solution for 2 h followed by rins-
ing in sterile water. The frame and seeding plate were placed inside a
sterile petri dish such that the seeding plate was raised and had no di-
rect contact with the petri dish. The collagen coated scaffolds from the
incubator were inserted into the holes in the seeding plate. A suspen-
sion containing 250,000 cells in 20 μl of media was prepared and loaded
into each scaffold. After seeding, the petri plate was incubated at 37 °C
for 3 h to allow the cells to attach to the scaffold. Every hour the loading
platewas inverted upside down to enable better cell inﬁltration into the
scaffold. Finally the scaffolds were removed from the seeding plate and
transferred into a 24 well plate. 1 ml of cell culture mediumwas added
to each well. The medium was refreshed every 2 days and old medium
was collected for cellular functionality assays. On days 4, 8 and 12 of the
culture period, two scaffolds from each time point were sacriﬁced and
used for live/dead staining.
2.3.4. Biochemical assays
Cell proliferation was estimated using the colorimetric indicator
alamarBlue® assay (Life Technologies). The cell-scaffold constructs
were transferred into a 24 well plate each containing 1 ml of RPMI
and alamarBlue® solution (in a 10:1 ratio) and incubated for 2 h in a hu-
midiﬁed incubator at 37 °C. The absorbance of the extracted dye, which
is proportional to the number of cells attached to the scaffold, wasmea-
sured spectrophotometrically using a microplate reader (PerkinElmer,
USA) atwavelengths of 570nm. Three independent scaffoldsweremea-
sured in triplicates, and the background (i.e., alamarBlue® absorbance
measured at day 0) was subtracted.
For the HepG2 functionality test, extracellular concentration of
albumin secretion from the HepG2 cells was determined by using an
enzyme-linked immunosorbent assay (ELISA) (Bethyl Laboratories,
USA) according to the manufacturer's instructions. All samples were
measured in triplicates and the standard deviation (SD) of mean was
determined from 3 independent scaffolds. The absorbance was mea-
sured at 450 nm using a spectrophotometer (PerkinElmer, USA).
2.3.5. Cell imaging
To visualise cell viability in the scaffolds, a live/dead-assay was per-
formed using a live/dead cell imaging kit (Life Technologies LIVE/
DEAD® Cell Imaging Kit), which is based on a cell-permeable dye for
staining of live cells (excitation/emission 488 nm/515 nm) and a cell-
impermeable dye for staining of dead and dying cells (excitation/
emission 570 nm/602 nm). Brieﬂy, the cell-laden scaffolds were re-
moved from the culture medium and gently washed with PBS. They
were then incubated in the dye solution for 30 min at 37 °C (as per
manufacturer's instructions). The scaffoldswere imaged using a ﬂuores-
cence microscope (Zeiss Axio Observer, ZI). 3D reconstructions were
compiled from 20 imaged sections (each of 30 μm thickness).
To visualise the cell proliferation and distribution through the cross
section of the scaffolds, cell-laden scaffolds were stained with cell-
permeable nuclear stain Hoechst 33342 (NucBlue® Live Ready Probes®
Reagent, life technologies) for live cell nuclei and ethidiumhomodimer-
1 (life technologies) for dead cell nucleus for 10min. The scaffolds were
then dissected longitudinally using a sterile scalpel and each section
was observed under a ﬂuorescence microscope. 3D reconstructions
were compiled from 20 imaged sections (each of 30 μm thickness).
An immunoﬂuorescence study was performed to visualise the
morphology of cells attached to the scaffold surface: After 12 days of
cell growth, the cell-laden scaffolds were immunostained with beta-
tubulin as cell cytoskeleton and nucleus. The construct was ﬁxed (4%
paraformaldehyde), permeabilized (30 min, 0.1% Triton X-100 in phos-
phate buffered saline (PBS)), and blocked (30 min, 0.1% Tween 20 and
1% bovine serum albumin in PBS) for unspeciﬁc binding of the antibod-
ies. The construct was stained with primary antibody as monoclonal
anti-α-tubulin IgG1 (2 h, 1:200, Life Technologies) followed by TO-
PRO-3 nuclear stain (1:1000, Life Technologies). The scaffold was then
cut through the centre using a sterile scalpel and visualised under a
Zeiss ApoTome ﬂuorescencemicroscope. 3D reconstructionswere com-
piled from 20 imaged sections (each having a thickness of 5 μm).
3. Results
3.1. Scaffold fabrication
Scaffolds were fabricated by casting PDMS around sacriﬁcial moulds
printed using two different inﬁll patterns (woodpile and hexagonal)
and four different inﬁll densities. Photographs and SEM images of the
printed moulds and resulting PDMS scaffolds of the two different inﬁll
patterns are shown in Fig. 2. The scaffolds possessed well-deﬁned, po-
rous structures. The square and hexagonal pore structure of both PVA
moulds and PDMS scaffoldswere observed to be uniform and consistent
(Fig. 2(a, b, e, f)). The structural features of the PVAmould are faithfully
replicated in the PDMS scaffold (Fig. 2(c, d, g, h)).
Thewoodpile inﬁll pattern results in structures comprising orthogo-
nal arrays of ﬁlaments with the centre-to-centre spacing between adja-
cent ﬁlaments differing based on the chosen inﬁll density (Fig. 3). Inﬁll
densities of 20, 40, 60 and 80% produces structures where ﬁlaments in a
layer had a distances of 1482, 593, 253 and 78 μm respectively. As the
inﬁll density increases, the centre-to-centre spacing of the ﬁlaments in
the PVAmould decreases (Fig. 3a–d). SEM images of themould showed
that the printed PVA ﬁlaments have an elliptical cross-section with a
width of 400 μm and a height of 200 μm (Supplementary ﬁgure). The
channels in the resulting PDMS scaffold have an elliptical proﬁle
from a cross section view (width 344 μm, height 190 μm) (shown in
Supplementary Fig. 5) and a square proﬁle (average side length 344
um) from the top view. The channel dimensions in the PDMS scaffold
are slightly smaller than the dimension of the PVA ﬁlaments of the
mould due to shrinkage of PDMS during the curing process. The channel
to channel distance varied from 1.4 mm at 20% inﬁll density down to
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78 μm at 80% inﬁll density of the printed mould. Thus the employed
3D printing technique enables the layer by layer assembly of a differ-
ent number of PVA ﬁlaments forming a porous 3D mould. To demon-
strate the scalability of the fabrication process, a larger cubic mould
(75 cm3) was fabricated and employed for generating a replica PDMS
scaffold with the same dimensions. Fig. 2(i) shows an image of two
cubic moulds of dimensions 1 cm3 and 75 cm3 printed using 80% inﬁll
settings and Fig. 2(j) shows the resulting PDMS scaffolds. Thus, as dem-
onstrated in Fig. 2, the periodic micro- and macroscale structural pat-
terns of the PVA mould were well replicated in the PDMS scaffolds.
3.2. Scaffold characterisation
3.2.1. Porosity
The experimentally determined porosity of fabricated scaffolds is
presented in Fig. 4. The porosity of the scaffolds varied linearly as a func-
tion of the inﬁll density of the printedmould from 19.9% porosity at 20%
inﬁll up to 81.2% porosity at 80% inﬁll (Fig. 4(a)).
3.2.2. Surface area
The calculated surface areas of a 1 cm3 fabricated scaffolds of varying
porosities are shown in Fig. 4(b). As the inﬁll density of the mould in-
creases from 20% to 80%, there is also a corresponding increase (from
52.5 cm2/cm3 to 150.9 cm2/cm3, respectively) in the surface area of
the channels within the PDMS scaffold volume. As the inﬁll density of
themould increases (Fig. 3(a–d)) the density of channels also increases
(Fig. 3(e–h)), which results in a linear increase in the total surface area
of the channels (Fig. 4(b)).
3.2.3. Mechanical testing
The assessment of the compressive characteristics of scaffolds is
known to play a signiﬁcant role inmany tissue-engineering applications
[34]. Compression tests of the scaffolds varying in porosity were per-
formed to assess the stress–strain relationship and evaluate their com-
pressive moduli (Fig. 5). The compressive modulus was determined
as the slope of the initial linear portion of the stress vs. strain curve
(12–20%). The compressive modulus were determined to be 1.84 ±
0.023, 0.84 ± 0.044, 0.36 ± 0.046 and 0.075 ± 0.047 MPa for the 20,
40, 60, and 80% porosity scaffolds, respectively. Results showed that
the energy absorption of the scaffolds is greatly reducedwith increasing
porosity. There is also a dramatic decrease in the compressive modulus
and in the stress at 20% strain with increasing scaffold porosity.
3.2.4. Surface roughness
The roughness of the 3D printed PVA mould and corresponding
PDMS scaffold was assessed using SEM. As shown in Fig. 6(a–d), the
presence of features such as pillars and grooves visible on the PVA
mould are faithfully replicated in the PDMS scaffolds. The roughness
of the PDMS scaffold was measured using an optical proﬁlometer. The
relative height and surface roughness are shown in the surface proﬁle
image (Fig. 6(e)) and the roughness parameters Ra and Rz of the
PDMS scaffold surface were measured to be approximately 1.036 μm
and 1.32 μm, respectively.
Fig. 2. Photographs of moulds and scaffolds with hexagonal (a, e) and woodpile (b, f) inﬁll patterns. SEM images of moulds and scaffolds with hexagonal (c, g) and woodpile (d, h) inﬁll
patterns. (i) Optical image of a 50 layered (1 cm3 cube) and 150 layered (75 cm3 cube) 3D printed PVAmould. (j) Optical image of 50 layered (1 cm3 cube) and 150 layered (75 cm3 cube)
PDMS scaffolds replicated from the mould (i). Scale bar in (i) and (j): 1 cm.
Fig. 3. SEM micrographs of 3D printed PVA moulds of 20, 40, 60 and 80% inﬁll densities (a–d) and corresponding PDMS scaffolds (e–h).
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3.3. Culturing cells in scaffold
3.3.1. Preparing scaffold for cell culturing (surface treatment)
To enable cell seeding and culturing within a porous scaffolds, it is
important to render the scaffold surface hydrophilic [35]. This is re-
quired to ensure that the cell suspension and culture media can be
absorbed within the scaffold pores. Oxygen plasma treatment was ap-
plied to the fabricated scaffolds to achieve this. Using this treatment,
the contact angle of the scaffold surface decreased from 122° ± 3.5° to
0° andmediawas able to inﬁltrate the pores of the scaffold (Supplemen-
tary Fig. 3).
3.3.2. Cell proliferation, viability and function
Following the surface treatment, the scaffolds were prepared for cell
culturing, seededwith cells, and incubated as described inMaterials and
methods. Cell viability and proliferation in the PDMS scaffolds with 80%
porosity were investigated over a 12 day culture period using biochem-
ical assays and imaging techniques. Cell proliferation in the scaffold was
quantiﬁed using the alamarBlue® assay. As shown in Fig. 7(a), the ﬂuo-
rescence intensity increased linearly over the culture period, indicating
an increase in the number of cells in the scaffolds with time. The func-
tionality of HepG2 cells cultured on the scaffolds was established by
measuring the extracellular albumin production (Fig. 7(b)). There was
an increase in albumin production from day 1 to day 12 of the cultures
which correlate with the increased cell density in the scaffolds.
Live/dead staining of the cell-scaffold construct was carried out to
assess the viability of cells cultured on the scaffolds. Fig. 8 shows the
confocal microscopy images of stained HepG2 cells on days 4, 8 and
12 of the culture period. Through the culture period, the density of living
cells (stained green) increased. On day 12 of the culture, a conﬂuent
layer of live cells was visible on the scaffolds. In all cases, no dead cells
were observed, so close to 100% cell viability was maintained through-
out the 12 days of culture period.
3.3.3. Cell inﬁltration and distribution within the scaffolds
At different time points during the culture period, the inﬁltration
and distribution of HepG2 cells within the PDMS scaffolds were investi-
gated. This was done by staining the scaffolds with nuclear stain
Hoechst 33342 (NucBlue® Live Ready Probes® Reagent, Life Technolo-
gies) for live cell nuclei and ethidium homodimer-1 (life technologies)
for dead cell nucleus. To visualise cell distribution through the cross sec-
tion of the scaffold, it was dissected along its central axis and imaged
using ﬂuorescence microscopy. Fig. 9 shows live cell nuclei (stained
blue) on the scaffold on days 4, 8 and 12 of the culture. Close to 100%
cell viability was observed (no dead cells could be seen)with cells pres-
ent throughout the cross section of the scaffold by the end of the culture
period. Scaffolds acquired from day 4 of the culture showed a higher
density of cells closer to the top and bottom face of the scaffold and
a sparse density of cells in the central regions of the scaffold. But with
longer culture time, cells appeared to proliferate and are seen to be
homogenously distributed throughout the channels of the scaffolds at
days 8 and 12.
Immunostaining of the scaffold was carried out to visualise themor-
phology of cells cultured on the scaffolds. Fig. 10 shows a homogeneous
and conﬂuent distribution of cells in the central region of the scaffold,
Fig. 4.Measured porosity (error bars = SD, n = 4) (a) and calculated surface to volume ratio (b) of scaffolds fabricated from mould with different inﬁll densities.
Fig. 5. (a) Stress–strain curves at 4 N load for different scaffolds, (b) compressive moduli of different PDMS scaffolds (error bars = standard deviation of 4 samples (n = 4)).
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highlighting the cytoskeleton beta-tubulin (green) and cell nucleus
(red). After 12 days of cell culture the cells were uniformly distributed
with high density of live cell in the centre of the scaffold. Immunoﬂuo-
rescence staining of the beta-tubulin demonstrated that the cells were
well attached to the surface with a spread-out cell morphology.
HepG2 cell adhesion on scaffold was also investigated through SEM
as shown in the Supplementary Fig. 5(a, b & c). After 4 days of culture,
the interaction between cells and the scaffold surface was examined.
Cells cultured on PDMS scaffold formed a well spread morphology and
exhibited excellent cell adhesion.
4. Discussion
In this paper, a new scalable and reproducible technique for fabricat-
ing 3D polymer scaffolds with deﬁned micro-architectures has been
presented. The technique is simple and involves casting of a desired
polymer material within a 3D printed water-soluble PVA mould,
which deﬁnes the microarchitecture/geometry of pores or channels
within the scaffold (Figs. 1–3). 3D printing parameters were optimised
to enable the production of reproducible moulds with high yield. The
technique was applied to fabricate ‘woodpile’ like scaffolds with regu-
larly spaced aligned polymer ﬁlaments in the x and y directions.
Scaffolds of porosities ranging from 20 to 80% and channel to channel
distances ranging from 78 μm to 1482 μmwere fabricated by specifying
the inﬁll density of themoulds. Scaffoldswith hexagonalmicro-features
were also obtained by using moulds with hexagonal inﬁll patterns.
The dimensions of the channels formed in the PDMS replica scaffolds
were ellipsoidal shaped with dimensions (344 μm × 190 μm) that
were slightly smaller than that of the ﬁlaments in the printed mould
(400 μm × 200 μm), due to shrinkage during elastomer curing.
Fig. 7. (a) Change in alamarBlue® ﬂorescence intensity of scaffolds over culture time. The ﬂuorescence intensity is proportional to the amount of cells. (b) Albumin production of HepG2
cells grown in PDMS scaffolds over 12 days of culture. Error bars indicate standard deviation of 3, independent scaffolds.
Fig. 6. Surface roughness analysis: SEM images showingmicrofeatures in the PVAmould surface (a) and PDMS scaffold (b, c & d). Surface proﬁle image of PDMS scaffold surface generated
from optical proﬁlometer (c) and zoom in of image c (d).
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We used the biocompatible elastomeric polymer PDMS to demon-
strate the ease of fabrication and scaling of scaffold structure, and
furthermore showed that it has potential as a scaffold for growth of
liver cells. However, the method has general applicability, meaning
that other mouldable materials can be structured in a similar manner.
To prove this point, poly-2-hydroxyethyl methacrylate (pHEMA) hy-
drogel scaffoldswere produced bymonomer/crosslinker casting around
PVA mould, photocrosslinking (Supplementary Fig. 4, and Material and
method in the Supplementary section) and subsequent dissolution of
the PVA mould.
The silicone elastomer PDMS is optically clear, and, in general, inert,
non-toxic, and non-ﬂammable. Its applications range from contact
lenses andmedical devices to additives in cosmetics and food products.
PDMS is also widely used as a material for microﬂuidic cell culturing
and the high number of publications using it indicates that it is a bio-
compatible material [36]. In general the effects of PDMS or silicones
on cells need to be evaluated on a case by case situation, as PDMS in
some situations has subtle effect on gene expression [37], butwe clearly
show here that the fabricated PDMS elastomer scaffold supports HepG2
growth and function (Figs. 7–10). This type of elastomer scaffold could
be used as a part of a life support system (LSS), e.g., an extracorporeal
liver [38] to temporarily relieve liver disease patients. In such applica-
tion PDMS offers several advantages: 1) It is easy to fabricate PDMS scaf-
fold structures using the PVA sacriﬁcial moulding method presented
here. 2) PDMS is a structurally strongmaterial for building largemeshes
(Fig. 2j). 3) PDMS is easy to sterilise by autoclavation (in contrast to
some hydrogels). 4) In contrast to hydrogels and many biodegradable
materials PDMS does not shrink, swell or warp signiﬁcantly with time
meaning that rationalﬂuidics optimisation canbedone aswell as robust
ﬂuidic connections for perfusions. 5) There are FDA approved medical
grade silicone elastomerswhich should be compatiblewith the here de-
scribed fabrication method.
It is well recognised that in order to be of clinical relevance, tissue
constructs must be scaled up to the macroscale, not only in length and
width, but also in thickness [20]. The presented fabrication method
overcomes existing challenges in creating thicker constructs in a simple
and reproducible manner by using precision assembly technology to
control the micro-architectural details. The scalability of the process
was demonstrated by producing a 75 cm3 large scaffold structure with
16,000 channels with a channel to channel distance of only 78 μm
(Fig. 2(j)). To our knowledge this is the largest scaffold ever to be pro-
ducedwith such small features sizes andwith somany structured chan-
nels. Thus the process enables amore efﬁcient scale up of scaffolds both
in size and in throughput, while also allowing versatility in the imple-
mentation of 3D microarchitectural designs.
It is well established that the micro-roughness of a scaffold surface
plays an important role in cell attachment and proliferation [39–42].
For this reason, the topological features of the scaffold were analysed
using SEM tomeasure the surface roughness. Geometrical and topolog-
ical features of the 3D printed PVA mould (Fig. 6a and b) were well
Fig. 8. Live/dead staining of HepG2 cells grown on the top and bottom parts of the PDMS scaffold for 4, 8 and 12 days. Scale bars represent 1 mm. (For interpretation of the references to
colour in this ﬁgure, the reader is referred to the web version of this article.)
Fig. 9.Visualisation of cell distribution through the central section of the scaffold stainedwith NucBlue® (live cells: blue) and ethidiumHomodimer-1 (EthD-1) (dead stain: red) ondays 4,
8, and 12 of HepG2 cell culturing. Scale bars: 1 mm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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replicated in the PDMS scaffold (Fig. 6c andd), giving the scaffoldmicro-
and nano-scale roughness. Such micro- and nano-scale roughness can
be an advantage for cell attachment and proliferation [43]. Our results
are in agreement with this: We observed conﬂuent layer of well-
attached cells with spread-out cell morphology (Fig. 10).
It is well known that cells respond to the material on which they
grow, both in terms of cytoskeleton, cellmorphology, cell differentiation
and function [45,46]. The mechanical properties of the fabricated
scaffolds of varying porosities were therefore characterised. The com-
pressive modulus of the scaffolds were estimated to be 1.84, 0.84,
0.34, 0.075 MPa for 20, 40, 60 and 80% porous scaffolds, respectively.
The inverse relationship between scaffold porosity and compressive
modulus is expected because scaffold with a higher porosity has less
material/mass to resist applied load and therefore has a lower compres-
sivemodulus. If the stiffness of the PDMS scaffold should be a problem it
can be adjusted by changing the ratio of pre-polymer to curing agent
[46] or by selecting hydrogel materials such as pHEMA (Supplementary
Fig. 4) could be used for casting the scaffold.
A highly available surface area in a scaffold can provide high ligand
density for initial cell attachment and proliferation [47]. We chose to
use the scaffold with the highest porosity (80%) for culturing cells since
it has the lowest compressive modulus, enables better mass transport,
and has the highest speciﬁc surface area (Fig. 4b) for cell attachment.
Until now it has been a challenge to maintain viable cells within
the inner cores of thick engineered tissue constructs due to insufﬁcient
oxygen and nutrient levels [33]. To regenerate artiﬁcial tissues a homo-
geneous cell distribution should be maintained inside the porous scaf-
fold structure [48,49]. The scaffolds presented in this work were able
to sustain cellswith 100%viability throughout the 12 day culture period.
Metabolic assays and total cell DNA quantiﬁcation assays do not give
information on cell inﬁltration and distribution inside the scaffold. In
order to visualise this aspect, the cell nucleus stained scaffolds were im-
aged at the top, bottom and cross sectional surfaces (Fig. 9). Cells were
seen to be uniformly distributed throughout the channels of the scaf-
folds and along the cross sectional length of the scaffold. The achieved
homogeneity can be attributed to the following: Firstly, the cell loading
procedure employed ensures an even distribution of cells throughout
the scaffolds. Secondly, the parallel and perpendicular structured chan-
nels in the scaffold allow sufﬁcient oxygen and nutrient mass transport
into the scaffold which promotes cell survival and proliferation. Thus at
the endof the culture period, cellswere seen to be uniformly distributed
throughout the scaffolds and along the cross sectional length of the scaf-
fold. Results from immunostaining clearly showed good HepG2 cell
morphology and attachment to the scaffold surface (Fig. 10). Cell func-
tionality was assessed by measuring albumin secretion of cells in scaf-
folds over time (Fig. 7b). The increase in albumin secretion through
the culture period indicates that the cells were able to maintain their
functionally while cultured in the presented 3D scaffold.
5. Conclusions
In this study, we have demonstrated a new technique for fabricating
scaffolds by 3D printing a sacriﬁcial water dissolvable PVA mould, cast-
ing polymer around it and subsequently dissolving the sacriﬁcial mould,
leading to structured scaffolds. Different designs of PDMS scaffoldswere
successfully prepared, and the fabrication technique allowed the tuning
of physical andmechanical properties by controlling the 3D printing pa-
rameter. By observing the biological activity of the hepatocytes in the
scaffold we conforms that along with maintaining very high cellular
viability the scaffold could also support high level of cellular albumin se-
cretion throughout the cultivation period. After 12 days of cell culturing
we observed a very high density of cells, homogeneously distribution
across the scaffold due to goodmass and oxygen transport into the scaf-
fold. The fabrication method can also be applied to other synthetic or
natural polymers as demonstrated by fabricating scaffolds in the hydro-
gel pHEMA. Furthermore, as we have demonstrated, the fabricated
scaffold can be scaled up to sizes relevant for bioartiﬁcial organs. In con-
clusion, the described process is scalable, compatible with cell culture,
rapid, and inexpensive.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.msec.2015.06.002.
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